Brevibloc Injection
Product Images NDC 10019-668

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brevibloc (NDC 10019-668). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Two-port Intravia Bag (Image 01)

An instructional diagram of an intravenous medication bag showing labeled components: a Medication Port used for withdrawing an initial bolus dose, and a Delivery Port for administering the injection. The bag is designed for intravenous infusion of the drug BREVIBLOC (esmolol hydrochloride).*

FDA Label Image

Esmolol Hydrochloride Structural Formula (Image 02)

Chemical structure of esmolol hydrochloride, the active ingredient in BREVIBLOC injection. The diagram shows the molecular configuration labeled with chemical groups associated with esmolol hydrochloride.*

FDA Label Image

Representative Brevibloc 20mg Novaplus Container Label 10019-668-10 (Image 03)

Brevibloc Premixed Double Strength Injection 2,000 mg/100 mL (20 mg/mL) is an intravenous injection of esmolol hydrochloride in sodium chloride, supplied in a 100 mL volume. The label states it is iso-osmotic, preservative-free, sterile, nonpyrogenic, and provides storage instructions. It is manufactured by Baxter Healthcare Company.*

FDA Label Image

Representative Brevibloc Novaplus Shipper Label 10019-668-10 (Image 04)

Label for BREVIBLOC PREMIXED Double Strength Injection, esmolol hydrochloride 20 mg/mL, in 10 x 100 mL single use INTRAVIA containers. Label includes storage instructions, manufacturer Baxter Healthcare Company, lot and expiration placeholders, NDC 10019-668-10, and barcode placement areas.*

FDA Label Image

Representative Brevibloc 10mg Novaplus Container Label 10019-672-10 (Image 05)

Label for BREVIBLOC PREMIXED Injection containing esmolol hydrochloride 10 mg/mL in sodium chloride, with a total volume of 250 mL. The label specifies it is an iso-osmotic, preservative-free intravenous injection for single use. Manufactured by Baxter Healthcare Company, the label includes storage instructions and cautions.*

FDA Label Image

Representative Brevibloc Novaplus Shipper Label 10019-672-10 (Image 06)

Brevibloc Premixed Injection label for intravenous use containing esmolol hydrochloride in sodium chloride at 10 mg/mL (2,500 mg/250 mL). The label indicates storage at 25°C, protection from freezing, and avoidance of excessive heat. It displays packaging of 10 single-use 250 mL Intravia containers and is labeled by Baxter Healthcare Corporation, Deerfield, IL, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.